Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature
| Autor: | Masakuni Noguchi, Miki Noguchi, Masafumi Inokuchi, Tomoko Kurita, Emi Morioka |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Breast Cancer Lymphedema Breast Neoplasms Multimodality Therapy Mastectomy Segmental 03 medical and health sciences 0302 clinical medicine medicine Humans In patient 030212 general & internal medicine Mastectomy business.industry Standard treatment Axillary Lymph Node Dissection General Medicine medicine.disease Lymphedema Lymphatic system Oncology Chemotherapy Adjuvant 030220 oncology & carcinogenesis Axilla Lymph Node Excision Female Radiotherapy Adjuvant Surgery Lymph Nodes Lymph Radiology Sentinel Lymph Node Reverse mapping business |
| Zdroj: | European Journal of Surgical Oncology. 46:2218-2220 |
| ISSN: | 0748-7983 |
| Popis: | Axillary lymph node dissection (ALND) can be avoided not only in patients with negative sentinel lymph nodes (SLNs) but also in those with one or two positive SLNs receiving breast or axillary radiation. However, ALND has remained the standard treatment for patients with clinically positive nodes (cN+). Although axillary reverse mapping (ARM) was developed to map and preserve arm lymphatic drainage during ALND, it could not be indicated for cN + patients because metastatic rate of ARM nodes is high. However, a new type of conservative ALND with ARM attempts to preserve ARM lymphatics and nodes except SLNs and other suspicious palpable nodes, including suspicious ARM nodes. This procedure allowed reduction of the rate of arm lymphedema without increasing axillary recurrence, although patients received postoperative chemotherapy and high-risk patients underwent axillary radiation. Thus, a traditional full ALND may not be necessary for cN + patients in the era of effective multimodality therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect